Susan Kim
Equibles does not estimate personal net worth.
About Susan Kim
Earlier roles on record: CFO at Pacific Biosciences Of California, Inc. (PACB) until December 6, 2024. Pacific Biosciences Of California, Inc. reported in an 8-K filed November 7, 2024 that Susan Kim resigned as Chief Financial Officer, effective December 6, 2024. Susan Kim has spoken on 16 earnings calls across 1 company, most recently for Pacific Biosciences Of California, Inc. on November 7, 2024. The companies whose calls Susan Kim spoke on are classified in the Healthcare sector.
“On November 5, 2024, Susan Kim notified the Company that she is voluntarily resigning as Chief Financial Officer of the Company effective on December 6, 2024, to accept a position at another organization.”
Susan Kim on recent calls
“I'm incredibly proud of what we've accomplished over the past four years, and I'm excited for PacBio's future. I am confident that under Christian's leadership, the team will continue to make tremendous strides in its mission to better human health through the promise of genomics.”
“I will be discussing non-GAAP results, which include non-cash stock-based compensation expense. I encourage you to review a reconciliation of GAAP to non-GAAP financial measures in our earnings press release.”
“As previously mentioned, we reported $38.8 million in product, service, and other revenue in the first quarter of 2024, compared to $38.9 million in the first quarter of 2023.”
“As discussed, we reported $58.4 million in product, service, and other revenue in the fourth quarter of 2023, which represented an increase of 113% from $27.4 million in the fourth quarter of 2022.”
“As discussed, we are pleased to have reported $55.7 million in product, service, and other revenue in the third quarter of 2023, which represented an increase of 72% from $32.3 million in the third quarter of 2022.”
Affiliation history
-
Start not stated–2024-12-06